Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00429676 · ClinicalTrials.gov registry record · Phase 2
Pilot Study of Haloperidol to Treat Critical Illness Delirium
A Phase 2 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT00429676 is a Phase 2 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 20 participants.
The verdict
NCT00429676, a Phase 2 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
The goal of this study is to determine whether haloperidol reduces the time on the breathing machine in critically ill patients with delirium.
Interventions
- DRUG Haloperidol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-12 |
| Est. Completion | 2007-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00429676
The ClinicalTrials.gov registry entry for NCT00429676 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Haloperidol is the first listed.
NCT00429676 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00429676 about?
NCT00429676 is a clinical study titled "Pilot Study of Haloperidol to Treat Critical Illness Delirium". The goal of this study is to determine whether haloperidol reduces the time on the breathing machine in critically ill patients with delirium.
What is the current status of trial NCT00429676?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2005-12. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00429676?
The interventions under investigation include: Haloperidol (DRUG).
Who is sponsoring clinical trial NCT00429676?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.